Objective: Aspiration of oropharyngeal or gastric contents into the lower respiratory tract is a common event in critically ill patients and can lead to pneumonia or pneumonitis. Aspiration pneumonia is the leading cause of pneumonia in the intensive care unit and is one of the leading risk factors for acute lung injury and acute respiratory distress syndromes. Despite its frequency, it remains largely a disease of exclusion characterized by ill-defined infiltrates on the chest radiograph and hypoxia. An accurate ability to diagnose aspiration is paramount because different modalities of therapy, if applied early and selectively, could change the course of the disease. This article reviews definitions, diagnosis, epidemiology, pathophysiology, including animal models of aspiration-induced lung injury, and evidence-based clinical management. Additionally, a review of current and potential biomarkers that have been tested clinically in humans is provided. Data Sources: Data were obtained from a PubMed search of the medical literature. PubMed "related articles" search strategies were used. Summary and Conclusions: Aspiration in the intensive care unit is a clinically relevant problem requiring expertise and awareness. A definitive diagnosis of aspiration pneumonitis or pneumonia is challenging to make. Advances in specific biomarker profiles and prediction models may enhance the diagnosis and prognosis of clinical aspiration syndromes. Evidence-based management is supportive, including mechanical ventilation, bronchoscopy for particulate aspiration, consideration of empiric antibiotics for pneumonia treatment, and lower respiratory tract sampling to define pathogenic bacteria that are causative. (Crit Care Med 2011; 39:818 -826) KEY WORDS: aspiration; aspiration pneumonitis; aspiration pneumonia, acute lung injury; acute respiratory distress syndrome, intensive care unit
A spiration-induced lung injury is often underdiagnosed in the clinical setting in the care of the critically ill and accounts for a significant proportion of acute pulmonary dysfunction (1) . Furthermore, it is recognized as an independent risk factor for subsequent development of pneumonia or acute lung injury or acute respiratory distress syndrome (ALI/ARDS). Despite the clinical importance of gastric aspiration-induced lung injury, the underlying mechanisms responsible for progression to severe inflammation and ALI/ ARDS are not fully understood. This concise review focuses on various clinical aspects of this form of acute lung injury to provide a guide for the bedside clinician in the intensive care unit. The lack of well-designed, randomized clinical studies on this subject has led to a number of generalizations and clinical paradigms that are clearly misleading. In this regard, the guidelines that are based on existing data and consensus statements are provided.
Additionally, because a major emphasis of our laboratory has been to elucidate mechanisms and identify distinct characteristics of the inflammation in gastric aspiration lung injury in animal models, we include this new information to supplement these guidelines in this review. Particular studies highlighted in coverage include research in rodent models (rats, mice) on how mild acid-induced aspiration injury can be greatly exacerbated if gastric food particles are also present (2) (3) (4) (5) (6) (7) . The potential for using statistical predictive modeling (8) to "diagnose" different forms of gastric aspiration (acid, gastric particles, and a combination of the two) based on inflammatory mediator and biomarker profiles is also discussed. Definition, epidemiology, diagnosis, and the basic guidelines for clinical management of gastric aspiration-induced lung injury are provided.
Definitions
Aspiration is defined as the inhalation of foreign material into the airways beyond the vocal cords (1, 9) . The content of the aspirate is variable and may comprise secretions, blood, bacteria, liquids, and food particles. Aspiration may be silent (or unwitnessed) or witnessed. Additionally, aspiration could involve repeated episodes of microaspiration that rarely cause acute symptoms (9) . Aspiration is different from regurgitation in which the reflux of gastric contents into the oropharynx or the esophagus is not associated with entry into the lungs.
Aspiration events can also be categorized as aspiration pneumonitis (chemical pneumonitis) or aspiration pneumonia (infectious process secondary to an aspiration event), although the differentiation between these two processes can be very difficult (1) . The precise timing and nature of the aspiration of bacteria is currently not well understood.
Incidence and Epidemiology
Gastric aspiration is a recognized complication of general anesthesia occurring in one of every 2000 -3000 anesthetics (1, 10 -12) . Gastric aspiration also frequently occurs in trauma or intensive care unit patients with altered states of consciousness (eg, head trauma, alcohol or drug-induced alterations in sensorium, cerebrovascular accidents). The inhalation of low pH gastric fluid and/or particulate food material leads to an initial pneumonitis that may or may not become complicated by subsequent bacterial pneumonia (1, 10, 13) . Unwitnessed gastric aspiration is thought to be potentially important in many unexplained cases of perioperative pulmonary dysfunction. However, a majority of gastric aspiration pneumonitis cases can be difficult to diagnose and is frequently mistaken for bacterial pneumonia leading to inappropriate treatment (1, 14, 15 ). The most challenging task for medical practitioners is the ability to differentiate between the two most common presentations of the aspiration syndromes: the inflammatory lung injury with aspiration pneumonitis and the bacterial aspiration pneumonia.
The true incidence of aspirationinduced lung injury is difficult to estimate considering that most aspiration events are silent or unwitnessed. In a prospective study of the critically ill, Methany and colleagues (16) , using bronchoalveolar lavage levels of pepsin as a surrogate marker of aspiration, estimated that at least one aspiration event occurred in 88.9% of patients.
The severity of lung injury after gastric aspiration ranges from mild, subclinical pneumonitis to a progressive respira-tory failure with significant morbidity and mortality. Gastric aspiration is a major direct cause of ALI and the more severe ARDS (1, 10, 17, 18) . ALI/ARDS typically involves a sudden, severe pulmonary inflammation and alveolarcapillary permeability injury that includes proteinaceous edema, hypoxemia, loss of lung compliance, and is also frequently associated with multiorgan system failure (18, 19) . Approximately onethird of patients with aspiration pneumonitis develop a more severe, protracted course associated with ALI/ARDS (12, 13, 20 -22) . The incidence of ALI/ ARDS has been variably reported to be 50,000 -150,000 cases per year in the United States with high associated mortality and morbidity (17, (23) (24) (25) (26) (27) (28) (29) . An analysis by Goss et al (27) has estimated the incidence of clinical ALI in the United States as 22-64 cases per 100,000 persons per year. In addition to severe acute respiratory failure, ALI/ARDS can also progress to a later "fibroproliferative" phase of disease that involves chronic lung injury with tissue remodeling and the initiation of fibrosis (18) . It has been hypothesized that one of the pathogenic mechanisms responsible for many cases of idiopathic pulmonary fibrosis is repeated chronic microaspiration. Aside from the substantial medical consequences, the economic cost of ALI/ARDS is significant with estimates of $3.5-6 billion and approximately $4150 per patient per day in the United States (29) . Mortality from ARDS has decreased somewhat since the initial description of this syndrome in 1967 (30) but remains unacceptably high at 30 -40% despite sophisticated medical intensive care (17, (23) (24) (25) (26) 29) . ALI/ARDS associated with aspiration pneumonitis carries a 30% mortality and accounts for up to 20% of all deaths attributable to anesthesia (31) (32) (33) .
Risk Factors
Aspiration is a frequently reported event in patients with altered levels of consciousness such as patients undergoing general anesthesia (11), elderly and nursing home residents (14, 15) , people with gastrointestinal and esophageal abnormalities (34) as well as patients with neurologic trauma and neuromuscular diseases (35) . The clinical manifestation of an aspiration event falls within a wide spectrum ranging from subclinical manifestations such as dry cough or dysphonia to a fulminant life-threatening failure such as ARDS. The pathogenic process can be further complicated by superimposed secondary infection, lung abscess, airway obstruction, exogenous lipoid pneumonia, and progression into chronic interstitial fibrosis (1) . The distinction between the two entities is important because although bacterial aspiration pneumonia needs to be treated with antibiotics, treatment of aspiration pneumonitis is supportive (1, 15) .
Patients at greatest risk for aspirationassociated ALI/ARDS in the perioperative period include those with reduced glottic competency resulting from extreme age, esophageal neuromuscular disease, endotracheal tube intubation, or impaired consciousness from ethanol intoxication, anesthesia, head trauma, or cerebrovascular accidents (1, 10) . Patients with low gastric pH levels, decreased gastroesophageal sphincter tone, or increased gastric pressure are also susceptible with additional predisposing conditions ranging from sepsis to pregnancy to diet. A complete list of potential risk factors is enumerated in Table 1 .
Pathogenesis of Different Forms of Gastric Aspiration: What Have We Learned From Animal Models?
Acid Aspiration. The acid component of gastric aspirates is frequently modeled by intratracheal instillation of hydrochloric acid in animal models. Lung injury in adult rats after the aspiration of dilute hydrochloric acid (ACID ϭ normal saline plus hydrochloric acid at a final pH of 1.25) is characterized by a biphasic response comprising an early insult that is characterized by stimulation of capsaicinsensitive neurons and direct caustic actions of low pH on airway epithelium followed by an acute neutrophilic inflammatory response at 4 -6 hrs (36) . These pathogenic mechanisms lead to the loss of pulmonary microvascular integrity and extravasation of fluid and protein into the airways and alveoli (36, 37) . In addition to mechanically increasing the work of breathing by increasing airway resistance and inhibiting the diffusion of oxygen, edema fluid contains plasma proteins and other substances that can directly interfere with the function of alveolar surfactant (for a comprehensive review of pulmonary surfactant activity and dysfunction in lung injury, see Notter [38] ). One indication of the importance of surfactant dysfunction in the pathophysiology of acid aspiration pneu- monitis is the finding in rats (39) that treatment with exogenous surfactant improves pulmonary function only after inhibitory plasma proteins are removed by lavage. Neutrophils are the inflammatory cellular response after aspiration of low pH gastric contents. Additionally, a number of local (pulmonary lavage) and systemic (blood) inflammatory mediators have been demonstrated in acid-induced lung injury (4, 5, 7, 40 -44) . Levels of the proximal proinflammatory cytokine, tumor necrosis factor-␣, are elevated after gastric aspiration (4, 44, 45) , and concentrations of several important chemotactic cytokines (ie, chemokines) in bronchoalveolar lavage are also increased. This includes elevated levels of the neutrophil chemotactic chemokine interleukin (IL)-8 in rabbits or the rodent homologs macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant-1 in rats during acid-induced lung injury (5, 7, 43) . Tumor necrosis factor-␣ and macrophage inflammatory protein-2 are required for the pathogenesis of acute pulmonary injury in rats given ACID (hydrochloric acid, pH 1.25) (4, 7). In addition, increases in leukocytederived oxidants and proteinases have been demonstrated in acid-induced lung injury (3, 40, 46) . Eicosanoids also play a role in acute acid-induced pulmonary injury and act in conjunction with cytokines to promote neutrophil infiltration and activation (41) . Activation of complement is additionally known to be important in the systemic response after acid aspiration (47) . Gastric Food Particle-Induced Lung Injury. Small nonacidified gastric particles (SNAP) for animal studies can be prepared from the stomach contents of rodents by a combination of washing in normal saline, filtration through gauze, autoclaving, and centrifugation (2, 5, 48) . The typical distribution of particle sizes in preparations of SNAP is bimodal with diameter peaks at approximately 4.5 and 13 m (average diameter Ͻ10 m) (2). After tracheal instillation of SNAP in rats, acute neutrophilic inflammation can be detected at 4 -6 hrs (2), but there is no initial edema as is observed in ACID. A monocytic response peaks at approximately 48 hrs postaspiration, at which time lung tissue exhibits signs of early granuloma formation. Tumor necrosis factor-␣, macrophage inflammatory protein-2, and cytokine-induced neutrophil chemoattractant-1 are among the acute inflammatory mediators elevated in la-vage from rats after the aspiration of SNAP (4, 5, 7) . Monocyte chemoattractant protein-1 is also elevated in rats after SNAP aspiration (5) and the importance of this mediator has been documented in several aspects of the innate pulmonary inflammatory response, including the development of granulomas (49 -53) . Monocyte chemoattractant protein-1 is produced by multiple cell types in lung injury, including pulmonary vascular endothelial cells and alveolar type 2 epithelial cells (52, 53) .
Combined Acid/Gastric Food Particle Aspiration Lung Injury. One emphasis of aspiration-related research noted earlier has been on animal models that involves two-hit insults (based on the contents of the aspirates themselves or additional stresses; ie, hyperoxia, bacterial seeding, lung contusion, or anesthesia). This work has shown that multiple insults can generate substantially more than additive severe pulmonary pathology than the sum of the individual component insults alone (3-5, 54 -59) . In terms of two-hit gastric aspirates, attention has been focused on a combination of acid plus small nonacidified gastric particles (CASP ϭ ACID ϩ SNAP). In both the rats and mice, the severity of lung injury from CASP aspiration is more severe than for either SNAP or ACID alone (4, 5, 56, 58) . Levels of albumin in bronchoalveolar lavage, which are indicative of loss of alveolarcapillary membrane integrity, are significantly higher in rats given CASP compared with ACID or SNAP ( Fig. 1A) . Arterial oxygenation is also dramatically reduced after intratracheal administration of CASP, with PaO 2 /FIO 2 ratios meeting the criteria for clinical ARDS in the 24-hr period after aspiration ( Fig. 1B) (5) . Increased lung injury based on bronchoalveolar lavage albumin levels after CASP aspiration in rodents is synergistic (greater than additive) compared with the individual component injuries of ACID or SNAP alone.
Data on leukocyte influx and cytokine/ chemokine production demonstrate an overexuberant proinflammatory response after the instillation of CASP compared with ACID or SNAP alone (4 -7, 48) . Numbers of neutrophils are dramatically increased in bronchoalveolar lavage from rodents given CASP compared with ACID or SNAP alone and remain high in the airspaces for 48 hrs postaspiration indicating continuing leukocytic infiltration (5, 6) . The degree of synergistic inflammation in CASP depends on the time delay between the administration of the first component injury (ACID) and the administration of the second (SNAP). The window of time for a synergistic proinflammatory lung injury exists for at least 8 hrs after ACID, but if SNAP is administered at 24 hrs after ACID, the severity of acute lung injury is decreased and the inflammatory response is suppressed compared with SNAP alone. Standard conditions for studies of CASP aspiration in our laboratory have involved either simultaneous instillation of ACID with SNAP or SNAP after ACID within 4 hrs (4 -7, 48) .
A broad spectrum of cytokines and chemokines have been studied to examine different patterns of inflammatory lung injury in the three forms of aspiration (5) . Levels of the CXC chemokine cytokineinduced neutrophil chemoattractant-1 (homolog of IL-8) in bronchoalveolar lavage were increased at both 4 and 6 hrs in rats given CASP and were higher than found in animals receiving SNAP or ACID. Bronchoalveolar lavage levels of the monotactic chemokine monocyte chemoattractant protein-1 were also elevated after CASP injury compared with SNAP or ACID at 6 hrs and continued to increase at 24 hrs. Levels of the modulatory cytokine IL-10 in bronchoalveolar lavage were increased at 6 hrs after either CASP or SNAP, but only rats that received CASP had increased IL-10 at 24 hrs. IL-10 levels were the single best predictor of lung injury severity based on albumin concentrations in bronchoalveolar lavage across all forms of aspiration studied (ACID, SNAP, CASP) at both 6 and 24 hrs (5) . A statistical correlation model that incorporated both IL-10 and monocyte chemoattractant protein-1 levels improved the prediction of the severity of lung injury at both time points.
These cytokines have been extensively studied in the context of ALI/ARDS. However, to date, there is no available data regarding the nature and pattern of cytokines that are elaborated specifically in the bronchoalveolar lavage or serum of patients with aspiration syndromes.
Diagnosis of Gastric Aspiration-Induced Lung Injury
Clinical Assessment. Aspiration may be completely asymptomatic or present with dramatic signs and symptoms that include wheezing, shortness of breath, cyanosis, hypotension, and hypoxia (1, 9) . A witnessed aspiration event is evident with the documentation of food particles or oral contents in the trachea-bronchial tree (9) . For instance, in patients who have sustained significant trauma, the aspirate may be made of blood and saliva (60) . These patients may subsequently deteriorate into ALI/ARDS or develop superimposed bacterial infection. The timing of the bacterial infection, whether related to the initial aspiration event or progressive migration of the bacteria into the distal bronchial tree, is a subject of intense controversy (1, 55) .
Unwitnessed gastric aspiration is one of the most difficult entities to diagnose. There are no gold standards for diagnosis of aspiration-induced lung injury. Oftentimes it is a disease of exclusion, in which other etiologies of hypoxia such as pulmonary edema, pulmonary embolism, or community-or hospital-acquired bacterial pneumonia have been ruled out. As-piration pneumonitis is diagnosed by a combination of hypoxia with a chest infiltrate that typically involves the dependant portions of the lungs. The portions of the lung affected may depend on the position in which the patient aspirates. Initially, the respiratory distress is much more severe than the radiographic changes would indicate, and many times the radiographic picture becomes more pronounced as the hypoxia and the clinical symptoms resolve. However, it is the differentiation of aspiration pneumonitis and aspiration pneumonia that poses the greatest challenge to the intensivist.
Specific Biomarkers. Numerous biomarkers have been studied in the context of aspiration-induced lung injury in humans and animals (61) . Additionally, similar markers have been investigated in the context of other lung injuries such as commu-nity-acquired pneumonia, hospital-acquired pneumonia, and sepsis, although not examined in human subjects with aspiration pneumonitis. A detailed discussion of these biomarkers is outside the scope of this review. Table 2 lists specific and potential biomarkers for aspiration that have been studied in humans and specific data pertaining to animal studies have been excluded.
Biomarker Profiles and Prediction Models. In addition to correlation analyses relating cytokine levels to lung injury severity, a complementary hierarchical cluster analysis was performed to summarize the degree of relationship among different cytokines and inflammatory cells in bronchoalveolar lavage at 6 and 24 hrs postaspiration (5) . Because of the complexity and interactions of different facets of the inflammatory response, correlational analyses involving cytokine and chemokine levels as noted here provide information that are suggestive rather than definitive. Nonetheless, these analyses support the potential of using information on local or systemic inflammatory mediators to better understand mechanisms and pathways that contribute to different forms of aspiration lung injury (62) . Furthermore, the existence of differences in inflammatory mediator responses in rats to various forms of aspiration (ACID, SNAP, CASP) suggests that it may ultimately be feasible to identify specific inflammatory mediator "signatures" to enhance the diagnosis and prognosis of clinical aspiration syndromes as described later (62) .
Management Principles
Although aspiration is considered a common event in the critically ill, the clinical consequences can vary. For the purpose of future discussion, it is assumed that aspiration pneumonitis and aspiration pneumonia are different clinical scenarios, although it is often difficult to separate the two entities. A proposed algorithm based on existing evidence and common practice patterns is highlighted in Figure 2 . It is additionally emphasized that the management principles adopted are based more on symptomatology and progression of the disease rather than the strict differentiation between aspiration pneumonitis and pneumonia.
Aspiration Pneumonitis. Most aspirates in the clinical scenarios are liquid in nature. It is the composition of the aspi- rate that determines the extent and progression of the injury on the pulmonary parenchyma. The course of pneumonitis can be broadly differentiated into two clinical phases. Phase 1 involves intense coughing or bronchospasm that occurs immediately after the aspiration event, whereas the second phase characterized by the onset of inflammation in the lung occurs over the next 4 -6 hrs (36) . Although there are limited data from randomized clinical trials regarding definitive therapy for aspiration events, there are certain guidelines that can be followed in managing these patients. Because it is impossible to enumerate all the therapeutic maneuvers that have been tested, only a few are discussed in detail.
Positioning and aggressive pulmonary care. After a witnessed aspiration event, the patient should be positioned so that further aspiration of gastric contents is significantly reduced. In an awake patient, this is best achieved by turning the head laterally and suctioning the oral and pharyngeal cavity (63) . The patient's bed can also be raised by 45°with the head up. The decision to intubate the patient is based on general neurologic status, degree of hypoxia, and hemodynamic stability of the patient. Additionally, patients with largevolume particulate aspiration may require intubation to facilitate future bronchoscopy (63, 64) . Nebulized bronchodilators may be administered for bronchospasm. In view of the recent aspiration event, attempts to institute noninvasive ventilation should be avoided. Mechanical ventilation should be continued ascribing to the current standards of a lung-protective strategy. Maneuvers to prevent recurrent aspira-tion episodes with gastric decompression such as placement of nasogastric tubes and connecting gastrostomy tubes to suction or gravity drainage should also be instituted.
Role of bronchoscopy. Aspirated material is frequently liquid in nature and disperses rapidly. Hence, routine bronchoscopy with lavage is not indicated. However, in the event that the aspirate is predominantly particulate in nature with clear radiographic evidence of lobar collapse or major atelectasis, therapeutic bronchoscopy is helpful (64) . The other major advantage of bronchoscopy is the sampling of the lower respiratory tract. The quantitative bacteriology obtained from the bronchoalveolar lavage samples cannot only guide definitive therapy and de-escalation of antibiotics, but also can result in discontinuation of antibiotics if cultures do not show significant bacterial growth (65) .
Role of empirical antibiotics. Aspiration is characterized in the early phase as acute pneumonitis. This inflammatory episode is often characterized by fever and leukocytosis. Although antibiotics are not necessary in the treatment of pneumonitis (1) , it is often difficult to distinguish aspiration pneumonitis from pneumonia. Additionally, bacteria from colonization of the stomach resulting from the common use of proton pump inhibitors or from the oropharynx may be aspirated with the gastric contents. Although there are no randomized trials on this subject, it is worthwhile to consider the following facts. In the context of treating ventilator-associated pneumonia, a short course of antibiotics has not been shown to have adverse effects as long as the antibiotics are de-escalated or discontinued based on quantitative microbiology. Furthermore, a recent survey suggested that a vast majority of intensivists were prescribing antibiotics in patients with suspected aspiration events (66) . A rational strategy would be to start antibiotics appropriate to cover ventilator-associated pneumonia (depending on the duration of stay in the intensive care unit) and de-escalate the antibiotic use based on appropriate definitive, quantitative cultures (usually within 72 hrs). It is emphasized that it is equally important to eliminate the antibiotics if the culture results do not show significant bacterial growth or contamination of the aspirated material. Antibiotics should also be considered in patients who have documented aspiration secondary to small bowel ob- struction or in patients with colonization of gastric contents (1) . It has been noted that anaerobic coverage was routinely instituted in the past for aspiration-induced lung injury. However, to date, available data do not indicate that anaerobic bacteria are a concern (67, 68). Role of steroids. Based on available data, steroid administration cannot be recommended for aspiration events. Although a single study showed early radiologic resolution of infiltrates after administration of steroids (69), subsequently, two large multicenter randomized studies have failed to show any benefit (70, 71) . Furthermore, at least one study reported a higher incidence of Gramnegative pneumonia in the patient arm that received steroids (72) .
Aspiration pneumonia. Aspirationinduced lung injury is a clear risk factor for development of pneumonia (16, 55) . Whether the aspiration of bacteria occurs at the initial time period or is a result of altered host-bacterial interaction is currently not well understood. Available evidence indicates that the bacteriology of aspiration pneumonia is not different from that of hospital or ventilatorassociated pneumonia (16, 73) . Once the diagnosis of aspiration pneumonia is definitively established, early administration of antibiotics is strongly recommended (74) . These may represent patients with persistent leukocytosis, fever, and infiltrates 48 hrs after the initial aspiration event. Additionally, identification of pathogenic bacteria in significant amount (Ͼ10 4 colony-forming units/mL in most intensive care units), either by protected brush specimen or bronchoalveolar lavages, is usually confirmatory for a diagnosis of aspiration pneumonia (65) . The choice of antibiotics may vary based on the local ecology of the intensive care unit. However, certain broad principles can be instituted (75) . It is appropriate to initiate early, empiric, broad-spectrum antibiotics with activity against Gramnegative bacteria (75) . Routine use of antibiotics with anaerobic coverage is not needed unless there is evidence of severe periodontal disease, necrotizing pneumonia, or lung abscess visualized in a computed tomographic scan (67, 68) . The duration of the antibiotics is similar to what is described for ventilator-associated pneumonia and although this subject is of intense debate, the recommended duration should be based on the patient's clinical response to antibiotics and may extend from 3 to 13 days (75, 76).
Future Directions
Despite major advances in understanding the pathophysiology of aspiration-induced lung injury in small animal models, there remains a significant gap in diagnosing unwitnessed gastric aspiration events as well as the ability to predict the likelihood of progression of the pulmonary insult to ALI/ARDS. One of the major problems in this regard is the absence of distinct diagnostic or prognostic signatures to diagnose this entity. With the development of microarray technology, there have been a number of studies that have focused on the identification of single or multiple gene products as biomarkers for diagnosis or prognosis. Recently the emerging field of whole-body or organ genomics has provided a methodology to develop classification models such as those applied in the field of ALI (77) . The ability to do so in combination with animal and well-designed human studies in the near future will likely result in the development of biomarkers that are useful in identifying the etiology and determining the potential pulmonary injury severity of aspiration events.
CONCLUSIONS
Aspiration-induced lung injury is a frequent problem that particularly affects the critically ill and is often misdiagnosed or a disease of exclusion. Patients after an aspiration event can present with a reversible noninfectious chemical pneumonitis (aspiration pneumonitis) or aspiration-related bacterial pneumonia (aspiration pneumonia), either of which could progress to ALI/ARDS. Animal studies have confirmed that a combination of acid and particulate matter aspirate results in severe, progressive lung injury compared with the individual gastric components of acid or particulate matter individually. Being able to distinguish the different aspiration syndromes could have significant prognostic and therapeutic implications. However, the basic mechanistic understanding of aspiration-induced lung injury from small animal studies has yet to produce clinically valid distinct "signatures" of aspiration pneumonitis vs. bacterial aspiration pneumonia. Investigations examining individual biomarkers in aspiration have come up with a number of shortcomings and the search for the clinically useful biomarker(s) continues. Finally, analysis of cytokines profiles has shown promise in animal models, but its relevance in clinical decisionmaking needs to be validated in well-designed clinical studies.
